Nasus Pharma Ltd Cash And Cash Equivalents At Carrying Value

Quick Answer

Nasus Pharma Ltd reported Cash And Cash Equivalents At Carrying Value of $1.24 million for the year ending 2025.

  • Nasus Pharma Ltd showed an increase of +335.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Nasus Pharma Ltd's annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Nasus Pharma Ltd's Cash And Cash Equivalents At Carrying Value has grown by 540.9%.
  • Historical annual values: Fiscal year 2025: $1.24 million | Fiscal year 2024: $284.0 thousand | Fiscal year 2023: $193.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: